Literature DB >> 14989458

Evolution of renal pathology in Fabry disease.

A Sessa1, M Meroni, G Battini, M Righetti, M Nebuloni, A Tosoni, G L Vago.   

Abstract

UNLABELLED: Fabry disease is a rare lysosomal storage disorder which results from deficient activity of the enzyme alpha-galactosidase A. The resultant deposition and progressive accumulation of glycosphingolipids in all types of body tissue leads to severe clinical manifestations involving the heart, CNS and kidney. Renal manifestations are observed relatively early in the course of the disease, and progression to end-stage renal failure is common in hemizygous males in the third to fifth decades of life. Renal biopsy specimens reveal evidence of diffuse intracytoplasmic glycosphingolipid accumulation, mainly affecting podocytes and epithelial cells of distal tubules, which are strikingly enlarged and vacuolated. On electron microscopy the deposits appear as typical osmiophilic inclusion bodies in the cytoplasm of all kinds of renal cells, and show a characteristic 'onion skin' or 'zebra' appearance. These pathological features are also evident in heterozygous females. Deposits occur before the development of renal impairment. As patients age, the disease progresses in cells throughout the kidney, and is associated with increasing glycosphingolipid accumulation.
CONCLUSION: The age-related evolution of renal pathology in Fabry disease is closely correlated with progressive intracellular deposition of glycosphingolipid and ultimately leads to end-stage renal failure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14989458     DOI: 10.1111/j.1651-2227.2003.tb00212.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  4 in total

1.  Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy.

Authors:  Carmen Valbuena; Elísio Carvalho; Manuela Bustorff; Mariana Ganhão; Sandra Relvas; Rosete Nogueira; Fátima Carneiro; João Paulo Oliveira
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

2.  Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report.

Authors:  Yosep Chong; Minyoung Kim; Eun Sil Koh; Seok Joon Shin; Ho-Shik Kim; Sungjin Chung
Journal:  BMC Med Genet       Date:  2016-10-24       Impact factor: 2.103

3.  Sometimes when you hear hoof beats, it could be a zebra: consider the diagnosis of Fabry disease.

Authors:  James O Burton; John P Dormer; Helen E Binns; Warren P Pickering
Journal:  BMC Nephrol       Date:  2012-07-31       Impact factor: 2.388

4.  Medullary thick ascending limb impairment in the GlatmTg(CAG-A4GALT) Fabry model mice.

Authors:  Hiroki Maruyama; Atsumi Taguchi; Yuji Nishikawa; Chu Guili; Mariko Mikame; Masaaki Nameta; Yutaka Yamaguchi; Mitsuhiro Ueno; Naofumi Imai; Yumi Ito; Takahiko Nakagawa; Ichiei Narita; Satoshi Ishii
Journal:  FASEB J       Date:  2018-03-19       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.